British Journal of Pharmacology · 1981 · 32 citations · 22 references
MedicineAnesthesiologyPharmacologyNeuropharmacologyPain MedicinePharmacodynamicsAnalgesiaAnalgesic PharmacologyOpioid AnalgesicsOpioid PharmacologyBlood PressureEndogenous Opioid ModulationIntravenous Naloxone AdministrationNaloxone PharmacologyOpioid Cardiovascular EffectsOpioid Peptide PharmacologyOpioid PharmacodynamicsSuperior Laryngeal Nerve Function
1 The effect of intravenous naloxone, and opiate antagonist, was studied on the pressor responses elicited by stimulation of afferent nerves (vagus and laryngeal superior nerves) in anaesthetized dogs. 2 Although naloxone (0.1 mg/kg i.v.) alone failed to modify basic blood pressure, the pressor responses induced by stimulation of either the vagus or laryngeal nerve were potentiated by naloxone. 3 Morphine (0.2 mg/kg i.v.) suppressed these two cardiovascular responses. These depressor effects of morphine were reversed by subsequent injection of naloxone (0.1 mg/kg i.v.). 4 The results suggest the involvement of endogenous opiate peptides in pressor reflexes elicited by stimulation of the afferent nerves.
22
Opiates and endogenous opioid peptides
John Kelly, Raymond Dingledine · Trends in Biochemical Sciences · 1977 · 1.3K citations
Medicine, Neuroscience, Pharmacology +12
Brain amines and models of experimental hypertension.
John Chalmers · Circulation Research · 1975 · 332 citations · Full text